First Turn Management, LLC: holdings and changes

Number 74 of the top 100 funds by copy return. First Turn Management, LLC reported 38 US stocks worth $753M for the quarter ending 2026-09-30 and changed 13 new, 3 added, 19 trimmed and 6 sold since 2026-06-30.

Copy return, 4 quarters+40.0%
US 500, same time+14.5%
Size$753M
Stocks38

Holdings

StockChangeWeightValueShares
ELVN
Enliven Therapeutics INC
5.84%$44M958,700
GH
Guardant Health INC
BUY5.19%$39M219,304
ABVX
Abivax Sa-Adr
TRIM -21%5.06%$38M384,592
ROIV
Roivant Sciences LTD
TRIM -26%4.79%$36M985,583
UTHR
United Therapeutics Corp
TRIM -29%4.32%$32M60,064
VRDN
Viridian Therapeutics INC
TRIM -9%4.17%$31M1,525,220
AXSM
Axsome Therapeutics INC
TRIM -26%3.98%$30M162,407
INSM
Insmed INC.
TRIM -7%3.72%$28M245,726
CELC
Celcuity INC
3.48%$26M329,101
CRL
Charles Riv Laboratories Intl INC
BUY3.40%$26M86,801
CYTK
Cytokinetics INC.
TRIM -32%3.13%$24M357,945
BBIO
Bridgebio Pharma INC
TRIM -44%3.10%$23M354,371
PRAX
Praxis Precision Medicines I
TRIM -6%3.05%$23M78,806
ORIC
Oric Pharmaceuticals INC
TRIM -22%2.82%$21M1,574,334
RGEN
Repligen INC.
BUY2.77%$21M108,436
TNGX
Tango Therapeutics INC
BUY2.54%$19M766,860
RVMD
Revolution Medicines INC
TRIM -78%2.52%$19M92,316
INBX
Inhibrx Biosciences INC
ADD +4%2.28%$17M171,512
NAMS
Newamsterdam Pharma Company
ADD +21%2.27%$17M702,396
MANE
Veradermics INC
BUY2.20%$17M136,718
COGT
Cogent Biosciences INC
TRIM -14%2.19%$16M514,976
DNTH
Dianthus Therapeutics INC
TRIM -38%2.09%$16M178,573
PVLA
Palvella Therapeutics INC Ne
TRIM -30%2.01%$15M109,871
RYTM
Rhythm Pharmaceuticals INC
1.99%$15M157,603
RCUS
Arcus Biosciences INC
BUY1.98%$15M577,693
ARWR
Arrowhead Pharmaceuticals, INC.
BUY1.94%$15M222,649
IRON
Disc Medicine INC
BUY1.92%$14M220,666
ERAS
Erasca INC Com
TRIM -25%1.78%$13M913,452
GRAL
Grail INC
BUY1.74%$13M93,727
KYMR
Kymera Therapeutics INC
ADD +11%1.68%$13M113,299
ASND
Ascendis Pharma A/S
TRIM -48%1.65%$12M54,594
QURE
Uniqure Nv
TRIM -24%1.49%$11M465,474
XENE
Xenon Pharmaceuticals INC
TRIM -51%1.47%$11M297,060
AEGLEA BIOTHER
Aeglea Biotherapeutics INC
BUY1.21%$9M102,541
SMMT
Summit Therapeutics
BUY1.13%$8M501,724
DFTX
Definium Therapeutics INC
BUY1.09%$8M216,531
PCVX
Vaxcyte INC
TRIM -69%1.04%$8M137,534
HNGE
Hinge Health INC Cl A Added
BUY0.97%$7M75,448
MIRM
Mirum Pharmaceuticals, INC.
SELL0%was $26M0
APOGEE THERA I
Apogee Thera INC
SELL0%was $18M0
SRRK
Scholar Rock Hldg Corp
SELL0%was $15M0
ORKA
Oruka Therapeutics INC
SELL0%was $15M0
SION
Sionna Therapeutics INC
SELL0%was $5M0
NUVALENT INC
Nuvalent INC
SELL0%was $3M0

Copy return each quarter

HeldFund copyUS 500
2024-03-31 → 2024-06-30-2.4%+4.0%
2024-06-30 → 2024-09-30+9.7%+5.4%
2024-09-30 → 2024-12-31-8.2%+2.1%
2024-12-31 → 2025-03-31-6.3%-4.6%
2025-03-31 → 2025-06-30+8.7%+10.5%
2025-06-30 → 2025-09-30+15.5%+7.8%
2025-09-30 → 2025-12-31+15.9%+2.4%
2025-12-31 → 2026-03-31+10.9%-4.6%
2026-03-31 → 2026-06-30+19.9%+14.8%
2026-06-30 → 2026-09-30-9.2%+2.1%

The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.

All top 100 funds, live

Other top funds

Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP